Cell Culture & Quality Control

Online Symposium

17 September 2024 | Online, BST (UTC+1)

Uniting experts from across the globe to elevate cell culture performance

Key Topics Covered


  • Cell culture and media optimisation
  •  Cell culture systems and models: 
    » 2D vs. 3D models 
    » Co-culture systems • 
  • Applications of cell culture 
    » Drug discovery and development 
    » Disease modelling 
    » Cell automation
  •   Advanced techniques and technologies e.g., Microphysiological systems 

Benefits of Attending

  • Meet with global key innovators in a focused symposium to hear the latest case studies in cell culture & quality control.  This program takes a deep dive into the novel technologies used in developing 3D models and enhancing cell culture alongside their latest applications, bringing together thought leaders from across the globe
  • Stay at the Forefront of Innovation by discovering strategies and best practices for optimising CHO cell lines and overcoming regulatory hurdles 
  • Discuss the latest advancements in the applications of cell culture, from disease modelling to developing organoids 
  • Followed by the release of the ‘Harnessing Cell Culture & Quality Control with Best Practice Approaches’ report detailing key insights, methodologies, and emerging trends discussed during the event for leveraging QC, cell culture & media effectively

Meet Our Expert Speakers

Cell Culture & Quality Control Online Symposium again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Confirmed speakers include:

Eric Wallenstein
Senior Director, Global Regulatory Affairs - CMC,
AskBio
Josh Bagley
CSO,
a:head bio AG
Paula Meleady
Associate Professor,
Dublin City University
Pedro Pinto
Lab Head Experimental Urology,
University of Greifswald
Tamara Zietek
Chief Scientific Officer,
Doctors Against Animal Experiments

Latest Resources

Imaging Starts Using Brand New Radiotracer from Nuclidium

The radiotracer is the first part of Nuclidium’s proposed ‘theranostic pipeline’ which aims to diagnose, stage, and then treat prostate cancer.

GHR Foundation Commits $15m to C2N Diagnostics for Tau Tangle Pathology Test for Diagnosing, Staging Alzheimer’s Disease

GHR’s total investment in C2N has now broken $50 million since 2020.

Study Analyses Predictive Biomarkers for COVID-19 ICU Patient Mortality

The study from the Federal University of Paraíba, Brazil analyses a series of haematological, biochemical, and inflammatory factors all contribute to the mortality of COVID-19 patients in the ICU.

Group Identify Prognostic Biomarker for SCLC and Treatment Using Chemotherapy

SCLC patients that express the gene PCDHB4 have a higher likelihood of developing a resistance to chemotherapy.

Proteomic Analysis of Serum Extracellular Vesicles Reveals Potential Biomarkers for Neuroblastoma

The proteomic analysis of extracellular vesicles is shaping up to be a promising biomarker discovery technique for diseases like neuroblastoma.

Blood Biomarkers Signal Increased Risk of Alzheimer's & MND After Multiple Rugby Concussions

Results that show rugby players that have sustained multiple concussions present with markers of neurodegenerative disease development.

Register Your Interest

Submit your details and a member of our team will be in touch